MORRISVILLE, N.C.--(BUSINESS WIRE)--Circassia Inc. announced today that it has successfully engaged with major primary care national sales partners to expand the distribution of NIOX VERO®, its FeNO ...
NIOX Group reported a strong 2025 performance, with revenues rising 17% to about £48.7m, driven by 7% growth in its core clinical business and a 77% surge in research revenues linked to an exceptional ...
Niox Group reported a strong financial performance for 2025 on Tuesday, with revenue and earnings ahead of market ...
Aerocrine AB announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. According to a release, Aerocrine has received ...
Aerocrine AB has announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. In a release, the Company said that it has received ...
Higher levels of fractional exhaled nitric oxide (FeNO) were found in patients with eosinophilic esophagitis (EoE) and might be able to provide a measurement of clinical treatment response in a subset ...
NICE, BTS, and SIGN guidelines: In November 2024, the National Institute for Health and Care Excellence (NICE) published the most significant update to UK guidelines in recent years. Jointly released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results